China Shineway Pharmaceutical Group Limitedの主要な財務諸表は何ですか?
CSWYYの主要な財務比率は何ですか?
China Shineway Pharmaceutical Group Limitedの収益はセグメントまたは地域別にどのように分けられていますか?
China Shineway Pharmaceutical Group Limitedは収益を上げていますか?
China Shineway Pharmaceutical Group Limitedに負債はありますか?
China Shineway Pharmaceutical Group Limitedの発行済株式数は何株ですか?
主要データ
前終値
$19.25
始値
$22.08
当日レンジ
$19.25 - $22.54
52週レンジ
$18.53 - $22.54
取引高
1
平均取引高
0
1株当たり利益(TTM)
3.09
配当利回り
--
時価総額
$727.0M
China Shineway Pharmaceutical Gとは何ですか?
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 2,867 full-time employees. The company went IPO on 2004-12-02. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The firm operates its business in mainland China and Hong Kong markets.